Atria Wealth Solutions’s VanEck Pharmaceutical ETF PPH Stock Holding History

Atria Wealth Solutions’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$241K	Hold	2,739	–	–	0.01%	1275
2025 Q1	$250K	Sell	2,739 -785	-22%	-$70.7K	﹤0.01%	1590
2024 Q4	$304K	Sell	3,524 -416	-11%	-$37.6K	﹤0.01%	1540
2024 Q3	$374K	Sell	3,940 -7,072	-64%	-$672K	﹤0.01%	1386
2024 Q2	$1.01M	Sell	11,012 -6,351	-37%	-$567K	0.01%	899
2024 Q1	$1.57M	Buy	17,363 +13,642	+367%	+$1.19M	0.02%	714
2023 Q4	$303K	Sell	3,721 -10,667	-74%	-$836K	﹤0.01%	1490
2023 Q3	$1.15M	Buy	14,388 +11,088	+336%	+$894K	0.02%	756
2023 Q2	$260K	Sell	3,300 -14,625	-82%	-$1.14M	﹤0.01%	1524
2023 Q1	$1.39M	Buy	+17,925	New	+$1.38M	0.02%	682

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Atria Wealth Solutions's PPH Position: Q2 2025 in Review

Atria Wealth Solutions held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2025 at 2,739 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #1275.

Atria Wealth Solutions first reported a position in PPH in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.57M in Q1 2024. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

Atria Wealth Solutions held 2,739 shares of VanEck Pharmaceutical ETF worth $241K as of Q2 2025.
Atria Wealth Solutions left its VanEck Pharmaceutical ETF share count unchanged in Q2 2025.
VanEck Pharmaceutical ETF made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1275 holding.
Atria Wealth Solutions first reported a position in VanEck Pharmaceutical ETF in Q1 2023 and has held it in 10 quarters since.
Atria Wealth Solutions's VanEck Pharmaceutical ETF position peaked at $1.57M in Q1 2024.
129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.